After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Most recently, Yahoo Finance reported about the stock as it publicized that Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
ORGO belongs to the Healthcare sector of the NASDAQ while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Organogenesis Holdings Inc is $460.82M. A total of 0.51 million shares were traded on the day, compared to an average of 752.39K shares.
Insider Activity
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, ORGO has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 7 SELLs from insiders. Insiders purchased 0 shares during that period but sold 65,992.
In the most recent transaction, ERANI ALBERT sold 17,972 shares of ORGO for 4.28 per share on Jan 10. After the transaction, the 10% Owner now owns 59,007,134 company shares. In a previous transaction on Jan 10, ERANI ALBERT sold 17,972 shares at 4.28 per share. ORGO shares that 10% Owner owns now total 59,007,134.
Among the insiders who sold shares, ERANI ALBERT disposed of 197,921 shares on Jan 09 at a per-share price of $4.37. This resulted in the 10% Owner holding 59,025,106 shares of ORGO after the transaction. In another insider transaction, ERANI ALBERT sold 197,921 shares at $4.37 per share on Jan 09. Company shares held by the 10% Owner now total 59,025,106.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for ORGO in the last 3 months, the mean price target is $4.83 with high estimates of $6.00 and low estimates of $3.50. In terms of 52-week highs and lows, ORGO has a high of $4.70 and a low of $1.79.
As of this writing, ORGO has an earnings estimate of $0.01 per share for the current quarter. EPS was calculated based on a consensus of 3 estimates, with a high estimate of $0.02 per share and a lower estimate of -$0.01. The company reported an EPS of $0.04 in the last quarter, which was 100.00% higher than expectations of $0.02.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ORGO’s latest balance sheet shows that the firm has $113.93M in Cash & Short Term Investments as of fiscal 2021. There were $132.30M in debt and $82.70M in liabilities at the time. Its Book Value Per Share was $2.11, while its Total Shareholder’s Equity was $241.34M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ORGO is Buy with a score of 4.33.
